Cargando…
COVID‐19‐associated thrombotic angiopathy improved after plasma exchange
Utilization of therapeutic plasma exchange in select patients with COVID‐19 microangiopathy may provide useful treatment by modulation of inflammatory cytokines and coagulation cascade to maintain homeostasis.
Autores principales: | Elkayam, Natalie, Raju, Gagan, Huang, Yiwu, Lipshitz, Jay, Peeke, Stephen, Bluth, Martin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614092/ https://www.ncbi.nlm.nih.gov/pubmed/34853683 http://dx.doi.org/10.1002/ccr3.4991 |
Ejemplares similares
-
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016) -
Combination of plasma exchange and haemofiltration for treating thrombotic microangiopathy in children
por: Huang, Jun, et al.
Publicado: (2020) -
The Oxidative Modification of Von Willebrand Factor Is Associated with Thrombotic Angiopathies in Diabetes Mellitus
por: Oggianu, Laura, et al.
Publicado: (2013) -
Refractory Thrombotic Thrombocytopenic Purpura to Therapeutic Plasma Exchange
por: Kiamos, Amy, et al.
Publicado: (2022) -
The Efficacy and Safety of Plasma Exchange in the Treatment of Thrombotic Thrombocytopenic Purpura
por: Pan, Zhilan, et al.
Publicado: (2022)